PMID- 28710147
OWN - NLM
STAT- MEDLINE
DCOM- 20180423
LR  - 20230216
IS  - 2156-5376 (Electronic)
IS  - 2161-8313 (Print)
IS  - 2161-8313 (Linking)
VI  - 8
IP  - 4
DP  - 2017 Jul
TI  - Dietary Guidelines for Breast Cancer Patients: A Critical Review.
PG  - 613-623
LID - 10.3945/an.116.014423 [doi]
AB  - Current dietary guidelines for breast cancer patients (BCPs) fail to address 
      adequate dietary intakes of macro- and micronutrients that may improve patients' 
      nutritional status. This review includes information from the PubMed and Biomed 
      Central databases over the last 15 y concerning dietary guidelines for BCPs and 
      the potential impact of a personalized, nutrient-specific diet on patients' 
      nutritional status during and after antineoplastic treatment. Results indicated 
      that BCPs should receive a nutritional assessment immediately after diagnosis. In 
      addition, they should be encouraged to pursue and maintain a healthy body weight 
      [body mass index (BMI; in kg/m(2)) 20-24.9], preserving their lean mass and 
      avoiding an increase in fat mass. Therefore, after nutritional status diagnosis, 
      a conservative energy restriction of 500-1000 kcal/d could be considered in the 
      dietary intervention when appropriate. Based on the reviewed information, we 
      propose a personalized nutrition intervention for BCPs during and after 
      antineoplastic treatment. Specifications in the nutritional therapy should be 
      based on the patients' nutritional status, dietary habits, schedule, activities, 
      and cultural preferences. BCPs' daily energy intake should be distributed as 
      follows: <30% fat/d (mainly monounsaturated and polyunsaturated fatty acids), 
       approximately 55% carbohydrates (primarily whole foods such as oats, brown rice, and fruits), 
      and 1.2-1.5 g protein ⋅ kg(-1) ⋅ d(-1) to avoid sarcopenic obesity. Findings 
      suggest that 5-9 servings/d of fruits ( approximately 150 g/serving) and vegetables ( approximately 75 
      g/serving) should be encouraged. Garlic and cruciferous vegetables must also be 
      part of the nutrition therapy. Adequate dietary intakes of food-based macro- and 
      micronutrients rich in beta-carotene and vitamins A, E, and C can both prevent 
      deterioration in BCPs' nutritional status and improve their overall health and 
      prognosis.
CI  - (c) 2017 American Society for Nutrition.
FAU - Limon-Miro, Ana Teresa
AU  - Limon-Miro AT
AUID- ORCID: 0000-0002-4811-5304
AD  - Department of Nutrition, Research Center for Food and Development, Hermosillo, 
      Sonora, Mexico; and.
FAU - Lopez-Teros, Veronica
AU  - Lopez-Teros V
AUID- ORCID: 0000-0003-1429-4911
AD  - Department of Chemical and Biological Sciences, University of Sonora, Hermosillo, 
      Sonora, Mexico.
FAU - Astiazaran-Garcia, Humberto
AU  - Astiazaran-Garcia H
AUID- ORCID: 0000-0002-2452-0057
AD  - Department of Nutrition, Research Center for Food and Development, Hermosillo, 
      Sonora, Mexico; and hastiazaran@ciad.mx.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170714
PL  - United States
TA  - Adv Nutr
JT  - Advances in nutrition (Bethesda, Md.)
JID - 101540874
RN  - 0 (Dietary Carbohydrates)
RN  - 0 (Dietary Fats)
RN  - 0 (Dietary Fiber)
RN  - 0 (Dietary Proteins)
RN  - 0 (Micronutrients)
SB  - IM
MH  - Body Mass Index
MH  - Breast Neoplasms/*therapy
MH  - *Diet
MH  - Dietary Carbohydrates/administration & dosage
MH  - Dietary Fats/administration & dosage
MH  - Dietary Fiber/administration & dosage
MH  - Dietary Proteins/administration & dosage
MH  - Female
MH  - Fruit
MH  - Health Behavior
MH  - Humans
MH  - Micronutrients/administration & dosage
MH  - Nutrition Assessment
MH  - *Nutrition Policy
MH  - Nutritional Status
MH  - Observational Studies as Topic
MH  - Randomized Controlled Trials as Topic
MH  - Vegetables
PMC - PMC5502868
OTO - NOTNLM
OT  - dietary assessment
OT  - drug-nutrient interaction
OT  - food-based intervention
OT  - macronutrients and micronutrients in breast cancer
OT  - personalized diet
COIS- Author disclosures: ATL-M, VL-T, and HA-G, no conflicts of interest.
EDAT- 2017/07/16 06:00
MHDA- 2018/04/24 06:00
PMCR- 2018/07/01
CRDT- 2017/07/16 06:00
PHST- 2017/07/16 06:00 [entrez]
PHST- 2017/07/16 06:00 [pubmed]
PHST- 2018/04/24 06:00 [medline]
PHST- 2018/07/01 00:00 [pmc-release]
AID - S2161-8313(22)00692-5 [pii]
AID - 014423 [pii]
AID - 10.3945/an.116.014423 [doi]
PST - epublish
SO  - Adv Nutr. 2017 Jul 14;8(4):613-623. doi: 10.3945/an.116.014423. Print 2017 Jul.